Hyperinsulinemia may boost both hematocrit and iron absorption by up-regulating activity of hypoxia-inducible factor-1α

Medical Hypotheses

Volumn 61, Issue 5-6, 2003, Pages 567-573

  McCarty, M F ^a  

^a Pantox Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FERRITIN; GLUCOSE TRANSPORTER; GLYCOLYTIC ENZYME; GROWTH FACTOR; HEME; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IRON; SOMATOMEDIN C; TRANSFERRIN;

ARTICLE; BIOSYNTHESIS; BLOOD DONOR; BLOOD VESSEL; CANCER RISK; COLORECTAL CANCER; CORRELATION ANALYSIS; DIET; DISEASE ASSOCIATION; ERYTHROPOIESIS; FERRITIN BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; GLYCOLYSIS; HEALTH HAZARD; HEMATOCRIT; HORMONE ACTION; HUMAN; HYPERINSULINEMIA; HYPOXIA; INSULIN RESISTANCE; IRON ABSORPTION; IRON DEFICIENCY; IRON OVERLOAD; IRON STORAGE; MEAT; NONHUMAN; OMNIVORY; PHLEBOTOMY; PRIORITY JOURNAL; PROTEIN FUNCTION; RETICULOCYTE; UPREGULATION;

ANIMALIA;

EID: 0242635837     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(03)00231-7     Document Type: Article

References (90)

1. Moan A., Nordby G., Os I., Birkeland K. I., Kjeldsen S. E. Relationship between hemorrheologic factors and insulin sensitivity in healthy young men. Metabolism 1994; 43: 423-427.
2. Lemne C., Brismar K. Haemoglobin, haematocrit, and insulin resistance. Diabetes Med 1996; 13: 1000.
3. Catalano C., Muscelli E., Natali A., Mazzoni A., Masoni A., Bernardini B. et al. Reciprocal association between insulin sensitivity and the haematocrit in man. Eur J Clin Invest 1997; 27: 634-637.
4. Facchini F. S., Carantoni M., Jeppesen J., Reaven G. M. Hematocrit and hemoglobin are independently related to insulin resistance and compensatory hyperinsulinemia in healthy, non-obese men and women. Metabolism 1998; 47: 831-835.
5. Barbieri M., Ragno E., Benvenuti E., Zito G. A., Corsi A., Ferrucci L. et al. New aspects of the insulin resistance syndrome: impact on haematological parameters. Diabetologia 2001; 44: 1232-1237.
6. Tuomainen T. P., Nyyssonen K., Salonen R., Tervahauta A., Korpela H., Lakka T. et al. Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men. Diabetes Care 1997; 20: 426-428.
7. Fernandez-Real J. M., Ricart-Engel W., Arroyo E., Balanca R., Casamitjana-Abella R., Cabrero D. et al. Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care 1998; 21: 62-68.
8. Kim N. H., Oh J. H., Choi K. M., Kim Y. H., Baik S. H., Choi D. S. et al. Serum ferritin in healthy subjects and type 2 diabetic patients. Yonsei Med J 2000; 41: 387-392.
9. Hua N. W., Stoohs R. A., Facchini F. S. Low iron status and enhanced insulin sensitivity in lacto-ovo vegetarians. Br J Nutr 2001; 86: 515-519.
10. Facchini F. S. Effect of phlebotomy on plasma glucose and insulin concentrations. Diabetes Care 1998; 21: 2190.
11. Semenza G. L. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999; 15: 551-578.
12. Minet E., Michel G., Remacle J., Michiels C. Role of HIF-1 as a transcription factor involved in embryonic development, cancer progression and apoptosis (review). Int J Mol Med 2000; 5: 253-259.
13. Wang G. L., Semenza G. L. Molecular basis of hypoxia-induced erythropoietin expression. Curr Opin Hematol 1996; 3: 156-162.
14. Ivan M., Kondo K., Yang H., Kim W., Valiando J., Ohh M. et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001; 292: 464-468.
15. Jaakkola P., Mole D. R., Tian Y. M., Wilson M. I., Gielbert J., Gaskell S. J. et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001; 292: 468-472.
16. Zelzer E., Levy Y., Kahana C., Shilo B. Z., Rubinstein M., Cohen B. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT. EMBO J 1998; 17: 5085-5094.
17. Zhong H., Chiles K., Feldser D., Laughner E., Hanrahan C., Georgescu M. M. et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 2000; 60: 1541-1545.
18. Semenza G. L. HIF-1: using two hands to flip the angiogenic switch. Cancer Metastasis Rev 2000; 19: 59-65.
19. Laughner E., Taghavi P., Chiles K., Mahon P. C., Semenza G. L. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HTF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 2001; 21: 3995-4004.
20. Richard D. E., Berra E., Gothie E., Roux D., Pouyssegur J. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J Biol Chem 1999; 274: 32631-32637.
21. Masuda S., Chikuma M., Sasaki R. Insulin-like growth factors and insulin stimulate erythropoietin production in primary cultured astrocytes. Brain Res 1997; 746: 63-70.
22. Susa J. B., Schwartz R. Effects of hyperinsulinemia in the primate fetus. Diabetes 1985; 34(Suppl 2): 36-41.
23. Widness J. A., Teramo K. A., Clemons G. K., Voutilainen P., Stenman U. H., McKinlay S. M. et al. Direct relationship of antepartum glucose control and fetal erythropoietin in human type 1 (insulin-dependent) diabetic pregnancy. Diabetologia 1990; 33: 378-383.
24. Salvesen D. R., Brudenell J. M., Snijders R. J., Ireland R. M., Nicolaides K. H. Fetal plasma erythropoietin in pregnancies complicated by maternal diabetes mellitus. Am J Obstet Gynecol 1993; 168: 88-94.
25. Frystyk J., Vestbo E., Skjaerbaek C., Mogensen C. E., Orskov H. Free insulin-like growth factors in human obesity. Metabolism 1995; 44: 37-44.
26. Frystyk J., Hussain M., Skjaerbaek C., Schmitz O., Christiansen J. S., Froesch E. R. et al. Serum free IGF-I during a hyperinsulinemic clamp following 3 days of administration of IGF-I vs. saline. Am J Physiol 1997; 273: E507-E513.
27. Endre T., Mattiasson I., Berglund G., Hulthen U. L. Insulin and renal sodium retention in hypertension-prone men. Hypertension 1994; 23: 313-319.
28. Reaven G. M. The kidney: an unwilling accomplice in syndrome X. Am J Kidney Dis 1997; 30: 928-931.
29. Facchini F. S., Stoohs R. A., Reaven G. M. Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate. Am J Hypertens 1996; 9: 1013-1017.
30. Skikne B. S., Cook J. D. Effect of enhanced erythropoiesis on iron absorption. J Lab Clin Med 1992; 120: 746-751.
31. Skikne B. S., Ahluwalia N., Fergusson B., Chonko A., Cook J. D. Effects of erythropoietin therapy on iron absorption in chronic renal failure. J Lab Clin Med 2000; 135: 452-458.
32. Aron D. C. Insulin-like growth factor I and erythropoiesis. Biofactors 1992; 3: 211-216.
33. Ratajczak J., Zhang Q., Pertusini E., Wojczyk B. S., Wasik M. A., Ratajczak M. Z. The role of insulin (INS) and insulin-like growth factor-I (IGF-I) in regulating human erythropoiesis. Studies in vitro under serum-free conditions-comparison to other cytokines and growth factors. Leukemia 1998; 12: 371-381.
34. Miyagawa S., Kobayashi M., Konishi N., Sato T., Ueda K. Insulin and insulin-like growth factor I support the proliferation of erythroid progenitor cells in bone marrow through the sharing of receptors. Br J Haematol 2000; 109: 555-562.
35. Christ E. R., Cummings M. H., Westwood N. B., Sawyer B. M., Pearson T. C., Sonksen P. H. et al. The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency. J Clin Endocrinol Metab 1997; 82: 2985-2990.
36. 3+) absorption, hypoxia and erythropoiesis in the mouse. Br J Haematol 1988; 68: 373-378.
37. Peters T. J., Raja K. B., Simpson R. J., Snape S. Mechanisms and regulation of intestinal iron absorption. Ann N Y Acad Sci 1988; 526: 141-147.
38. Pootrakul P., Kitcharoen K., Yansukon P., Wasi P., Fucharoen S., Charoenlarp P. et al. The effect of erythroid hyperplasia on iron balance. Blood 1988; 71: 1124-1129.
39. Hughes R. T., Smith T., Hesp R., Hulme B., Dukes D. C., Bending M. B. et al. Regulation of iron absorption in iron loaded subjects with end stage renal disease: effects of treatment with recombinant human erythropoietin and reduction of iron stores. Br J Haematol 1992; 82: 445-454.
40. Furuta G. T., Turner J. R., Taylor C. T., Hershberg R. M., Comerford K., Narravula S. et al. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J Exp Med 2001; 193: 1027-1034.
41. Narravula S., Colgan S. P. Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia. J Immunol 2001; 166: 7543-7548.
42. Fernandez-Moreno M. D., Serrano-Rios M., Prieto J. C. Identification of insulin receptors in epithelial cells from duodenum, jejunum, ileum, caecum, colon and rectum in the rat. Diabetes Metab 1987; 13: 135-139.
43. Buts J. P., De Keyser N., Marandi S., Maernoudt A. S., Sokal E. M., Rahier J. et al. Expression of insulin receptors and of 60-kDa receptor substrate in rat mature and immature enterocytes. Am J Physiol 1997; 273: G217-G226.
44. Laburthe M., Rouyer-Fessard C., Gammeltoft S. Receptors for insulin-like growth factors I and II in rat gastrointestinal epithelium. Am J Physiol 1988; 254: G457-G462.
45. Termanini B., Nardi R. V., Finan T. M., Parikh I., Korman L. Y. Insulinlike growth factor I receptors in rabbit gastrointestinal tract. Characterization and autoradiographic localization. Gastroenterology 1990; 99: 51-60.
46. Lee P. L., Gelbart T., West C., Halloran C., Beutler E. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms. Blood Cells Mol Dis 1998; 24: 199-215.
47. Schneider B. D., Leibold E. A. Regulation of mammalian iron homeostasis. Curr Opin Clin Nutr Metab Care 2000; 3: 267-273.
48. Oshaug A., Bugge K. H., Bjonnes C. H., Borch-Iohnsen B., Neslein I. L. Associations between serum ferritin and cardiovascular risk factors in healthy young men. A cross sectional study. Eur J Clin Nutr 1995; 49: 430-438.
49. Gillum R. F. Association of serum ferritin and indices of body fat distribution and obesity in Mexican American men - the Third National Health and Nutrition Examination Survey. Int J Obes Relat Metab Disord 2001; 25: 639-645.
50. Lakka T. A., Nyyssonen K., Salonen J. T. Higher levels of conditioning leisure time physical activity are associated with reduced levels of stored iron in Finnish men. Am J Epidemiol 1994; 140: 148-160.
51. Bartfay W. J., Bartfay E., Axelsson J., Sigurdsson S. B., Naimark B. The relationship of serum ferritin with sex and exercise in Canadians of Icelandic descent: implications for prevention of coronary artery disease. Can J Cardiol 1995; 11: 305-310.
52. Naimark B. J., Ready A. E., Sawatzky J. A., Boreskie S., Ducas J., Drinkwater D. T. et al. Serum ferritin and heart disease: the effect of moderate exercise on stored iron levels in postmenopausal women. Can J Cardiol 1996; 12: 1253-1257.
53. Brooks G. A., Henderson S. A., Dallman P. R. Increased glucose dependence in resting, iron-deficient rats. Am J Physiol 1987; 253: E461-E466.
54. Farrell P. A., Beard J. L., Druckenmiller M. Increased insulin sensitivity in iron-deficient rats. J Nutr 1988; 118: 1104-1109.
55. Hostettler-Allen R., Tappy L., Blum J. W. Enhanced insulin-dependent glucose utilization in iron-deficient veal calves. J Nutr 1993; 123: 1656-1667.
56. Borel M. J., Beard J. L., Farrell P. A. Hepatic glucose production and insulin sensitivity and responsiveness in iron-deficient anemic rats. Am J Physiol 1993; 264: E380-E390.
57. Riddle S. R., Ahmad A., Ahmad S., Deeb S. S., Malkki M., Schneider B. K. et al. Hypoxia induces hexokinase II gene expression in human lung cell line A549. Am J Physiol Lung Cell Mol Physiol 2000; 278: L407-L416.
58. Potashnik R., Kozlovsky N., Ben-Ezra S., Rudich A., Bashan N. Regulation of glucose transport and GLUT-1 expression by iron chelators in muscle cells-in culture. Am J Physiol 1995; 269: E1052-E1058.
59. Eisenstein R. S. Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu Rev Nutr 2000; 20: 627-662.
60. Sampson M. J., Williams T., Heyburn P. J., Greenwood R. H., Temple R. C., Wimperis J. Z. et al. Prevalence of HFE (hemochromatosis gene) mutations in unselected male patients with type 2 diabetes. J Lab Clin Med 2000; 135: 170-173.
61. Campo S., Restuccia T., Villari D., Raffa G., Cucinotta D., Squadrito G. et al. Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. Liver 2001; 21: 233-236.
62. Salonen J. T., Nyyssonen K., Korpela H., Tuomilehto J., Seppanen R., Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992; 86: 803-811.
63. Kim J. K., Kim Y. J., Fillmore J. J., Chen Y., Moore I., Lee J. et al. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 2001; 108: 437-446.
64. Danesh J., Appleby P. Coronary heart disease and iron status: meta-analyses of prospective studies. Circulation 1999; 99: 852-854.
65. Meyers D. G., Strickland D., Maloley P. A., Seburg J. K., Wilson J. E., McManus B. F. Possible association of a reduction in cardiovascular events with blood donation. Heart 1997; 78: 188-193.
66. Salonen J. T., Tuomainen T. P., Salonen R., Lakka T. A., Nyyssonen K. Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Epidemiol 1998; 148: 445-451.
67. Ascherio A., Rimm E. B., Giovannucci E., Willett W. C., Stampfer M. J. Blood donations and risk of coronary heart disease in men. Circulation 2001; 103: 52-57.
68. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997; 272: 20963-20966.
69. Heinecke J. W. Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis. Arterioscler Thromb Vasc Biol 2001; 21: 1261-1264.
70. Dabbagh A. J., Shwaery G. T., Keaney J. F. J., Frei B. Effect of iron overload and iron deficiency on atherosclerosis in the hypercholesterolemic rabbit. Arterioscler Thromb Vasc Biol 1997; 17: 2638-2645.
71. Kirk E. A., Heinecke J. W., LeBoeuf R. C. Iron overload diminishes atherosclerosis in apoE-deficient mice. J Clin Invest 2001; 107: 1545-1553.
72. Ascherio A., Willett W. C., Rimm E. B., Giovannucci E. L., Stampfer M. J. Dietary iron intake and risk of coronary disease among men. Circulation 1994; 89: 969-974.
73. Klipstein-Grobusch K., Grobbee D. E., den Breeijen J. H., Boeing H., Hofman A., Witteman J. C. Dietary iron and risk of myocardial infarction in the Rotterdam Study. Am J Epidemiol 1999; 149: 421-428.
74. Mello F. A., Meneghini R. In vivo formation of single-strand breaks in DNA by hydrogen peroxide is mediated by the Haber-Weiss reaction. Biochim Biophys Acta 1984; 781: 56-63.
75. Mello-Filho A. C., Meneghini R. Iron is the intracellular metal involved in the production of DNA damage by oxygen radicals. Mutat Res 1991; 251: 109-113.
76. Nascimento A. L., Meneghini R. Cells transfected with transferrin receptor cDNA lacking the iron regulatory domain become more sensitive to the DNA-damaging action of oxidative stress. Carcinogenesis 1995; 16: 1335-1338.
77. Stevens R. G., Beasley R. P., Blumberg B. S. Iron-binding proteins and risk of cancer in Taiwan. J Natl Cancer Inst 1986; 76: 605-610.
78. Stevens R. G., Jones D. Y., Micozzi M. S., Taylor P. R. Body iron stores and the risk of cancer. N Engl J Med 1988; 319: 1047-1052.
79. Stevens R. G. Iron and the risk of cancer. Med Oncol Tumor Pharmacother 1990; 7: 177-181.
80. Stevens R. G., Graubard B. I., Micozzi M. S., Neriishi K., Blumberg B. S. Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int J Cancer 1994; 56: 364-369.
81. Merk K., Mattsson B., Mattsson A., Holm G., Gullbring B., Bjorkholm M. The incidence of cancer among blood donors. Int J Epidemiol 1990; 19: 505-509.
82. Nelson R. L. Iron and colorectal cancer risk: human studies. Nutr Rev 2001; 59: 140-148.
83. Giovannucci E., Willett W. C. Dietary factors and risk of colon cancer. Ann Med 1994; 26: 443-452.
84. Guo W. D., Chow W. H., Zheng W., Li J. Y., Blot W. J. Diet, serum markers and breast cancer mortality in China. Jpn J Cancer Res 1994; 85: 572-577.
85. Weinberg E. D. Iron, infection, and neoplasia. Clin Physiol Biochem 1986; 4: 50-60.
86. Letendre E. D. Iron metabolism during infection and neoplasia. Cancer Metastasis Rev 1987; 6: 41-53.
87. Jurado R. L. Iron, infections, and anemia of inflammation. Clin Infect Dis 1997; 25: 888-895.
88. Weinberg E. D. Development of clinical methods of iron deprivation for suppression of neoplastic and infectious diseases. Cancer Invest 1999; 17: 507-513.
89. Barnard N. Food for Life - How the New Four Food Groups Can Save Your Life. New York: Three Rivers Press, 1993.
90. McCarty M. F. Vegan proteins may reduce risk of cancer, obesity, and cardiovascular disease by promoting increased glucagon activity [In Process Citation]. Med Hypotheses 1999; 53: 459-485.